Distribution of COPD Comorbidities and Creation of Acute Exacerbation Risk Score: Results from SCICP

References

• Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res. 2017;18(1):67. doi:10.1186/s12931-017-0548-3
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Tan W, Soriano JB. Global burden of COPD. Respirology. 2016;21(1):14–23. doi:10.1111/resp.12660
   PubMed Web of Science ®Google Scholar
• Zhu B, Wang Y, Ming J, Chen W, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353–1364. doi:10.2147/COPD.S161555
   PubMed Web of Science ®Google Scholar
• Negewo NA, Gibson PG, McDonald VM. COPD and its comorbidities: impact, measurement and mechanisms. Respirology. 2015;20(8):1160–1171.
   PubMed Web of Science ®Google Scholar
• Smith MC, Wrobel JP. Epidemiology and clinical impact of major comorbidities in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2014;9:871–888. doi:10.2147/COPD.S49621
   PubMed Web of Science ®Google Scholar
• Maselli DJ, Bhatt SP, Anzueto A, et al. Clinical epidemiology of COPD: insights from 10 years of the COPDGene Study. Chest. 2019;156(2):228–238. doi:10.1016/j.chest.2019.04.135
   PubMed Web of Science ®Google Scholar
• Mantero M, Rogliani P, Di Pasquale M, et al. Acute exacerbations of COPD: risk factors for failure and relapse. Int J Chron Obstruct Pulmon Dis. 2017;12:2687–2693. doi:10.2147/COPD.S145253
   PubMed Web of Science ®Google Scholar
• Halpin DM, Miravitlles M, Metzdorf N, Celli B. Impact and prevention of severe exacerbations of COPD: a review of the evidence. Int J Chron Obstruct Pulmon Dis. 2017;12:2891–2908. doi:10.2147/COPD.S139470
   PubMed Web of Science ®Google Scholar
• Maters GA, de Voogd JN, Sanderman R, Wempe JB. Predictors of all-cause mortality in patients with stable COPD: medical co-morbid conditions or high depressive symptoms. COPD. 2014;11(4):468–474. doi:10.3109/15412555.2014.898026
   PubMedGoogle Scholar
• Global initiative for chronic global initiative for chronic obstructive lung disease. Available from: http://gold-copd.html. Accessed June 28, 2021.
   Google Scholar
• Almagro P, Martinez-Camblor P, Miravitlles M, et al. External validation and recalculation of the CODEX index in COPD patients. A 3CIAplus Cohort Study. COPD. 2019;16(1):8–17. doi:10.1080/15412555.2018.1484440
   PubMedGoogle Scholar
• Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. doi:10.1164/rccm.201201-0034OC
   PubMed Web of Science ®Google Scholar
• Li Y, Ragland M, Austin E, et al. Co-morbidity patterns identified using latent class analysis of medications predict all-cause mortality independent of other known risk factors: the COPDGene((R)) Study. Clin Epidemiol. 2020;12:1171–1181. doi:10.2147/CLEP.S279075
   PubMed Web of Science ®Google Scholar
• Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of Chronic Obstructive Pulmonary Disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. doi:10.2147/COPD.S234942
   PubMed Web of Science ®Google Scholar
• Ouaalaya EH, Falque L, Dupis JM, et al. Susceptibility to frequent exacerbation in COPD patients: impact of the exacerbations history, vaccinations and comorbidities? Respir Med. 2020;169:106018. doi:10.1016/j.rmed.2020.106018
   PubMed Web of Science ®Google Scholar
• Vanfleteren L, Fabbri LM. Self-management interventions in COPD patients with multimorbidity. Eur Respir J. 2019;54(5):1901850. doi:10.1183/13993003.01850-2019
   PubMed Web of Science ®Google Scholar
• Maricoto T, Santos D, Carvalho C, Teles I, Correia-de-sousa J, Taborda-Barata L. Assessment of poor inhaler technique in older patients with asthma or COPD: a predictive tool for clinical risk and inhaler performance. Drugs Aging. 2020;37(8):605–616. doi:10.1007/s40266-020-00779-6
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Dransfield MT, Anderson JA, et al. Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial. Am J Respir Crit Care Med. 2018;198(1):51–57. doi:10.1164/rccm.201711-2239OC
   PubMed Web of Science ®Google Scholar
• Campo G, Pavasini R, Biscaglia S, Contoli M, Ceconi C. Overview of the pharmacological challenges facing physicians in the management of patients with concomitant cardiovascular disease and chronic obstructive pulmonary disease. Eur Heart J Cardiovasc Pharmacother. 2015;1(3):205–211. doi:10.1093/ehjcvp/pvv019
   PubMedGoogle Scholar
• Roversi S, Fabbri LM. Lung and heart interaction: chronic obstructive pulmonary disease and ischemic heart disease. G Ital Cardiol. 2018;19(3):153–160. doi:10.1714/2883.29073
   Web of Science ®Google Scholar
• Campo G, Pavasini R, Malagu M, et al. Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management. Cardiovasc Drugs Ther. 2015;29(2):147–157. doi:10.1007/s10557-014-6569-y
   PubMed Web of Science ®Google Scholar
• Carter P, Lagan J, Fortune C, et al. Association of cardiovascular disease with respiratory disease. J Am Coll Cardiol. 2019;73(17):2166–2177. doi:10.1016/j.jacc.2018.11.063
   PubMed Web of Science ®Google Scholar
• Giezeman M, Hasselgren M, Lisspers K, et al. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study. Int J Chron Obstruct Pulmon Dis. 2018;13:3857–3865. doi:10.2147/COPD.S175641
   PubMed Web of Science ®Google Scholar
• Gunes Y, Tuncer M, Guntekin U, et al. Reliability of symptoms suggestive of angina in patients with chronic obstructive pulmonary disease. Arq Bras Cardiol. 2009;92(5):334–338, 351–335, 364–338. doi:10.1590/s0066-782x2009000500005
   Web of Science ®Google Scholar
• Soumagne T, Guillien A, Roche N, et al. In patients with mild-to-moderate COPD, tobacco smoking, and not COPD, is associated with a higher risk of cardiovascular comorbidity. Int J Chron Obstruct Pulmon Dis. 2020;15:1545–1555.
   PubMed Web of Science ®Google Scholar
• Ogan N, Gunay E, Ekici B, et al. Morphological overview of cardiovascular comorbidities in chronic obstructive pulmonary disease: frank’s sign. Heart Lung. 2020;49(3):331–335. doi:10.1016/j.hrtlng.2020.01.008
   PubMed Web of Science ®Google Scholar
• Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007;99(5):636–641. doi:10.1016/j.amjcard.2006.09.112
   PubMed Web of Science ®Google Scholar
• Mouronte-Roibas C, Leiro-Fernandez V, Fernandez-Villar A, Botana-Rial M, Ramos-Hernandez C, Ruano-Ravina A. COPD, emphysema and the onset of lung cancer. A systematic review. Cancer Lett. 2016;382(2):240–244. doi:10.1016/j.canlet.2016.09.002
   PubMed Web of Science ®Google Scholar
• Eapen MS, Hansbro PM, Larsson-Callerfelt AK, et al. Chronic obstructive pulmonary disease and lung cancer: underlying pathophysiology and new therapeutic modalities. Drugs. 2018;78(16):1717–1740.
   PubMed Web of Science ®Google Scholar
• Sandelin M, Mindus S, Thuresson M, et al. Factors associated with lung cancer in COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:1833–1839. doi:10.2147/COPD.S162484
   PubMed Web of Science ®Google Scholar
• Dai J, Yang P, Cox A, Jiang G. Lung cancer and chronic obstructive pulmonary disease: from a clinical perspective. Oncotarget. 2017;8(11):18513–18524. doi:10.18632/oncotarget.14505
   PubMedGoogle Scholar
• Shin JI, Brusselle GG. Mechanistic links between COPD and lung cancer: a role of microRNA let-7? Nat Rev Cancer. 2013;14(1):70. doi:10.1038/nrc3477-c1
   Web of Science ®Google Scholar
• Paiva Ferreira LKD, Paiva Ferreira LAM, Monteiro TM, Bezerra GC, Bernardo LR, Piuvezam MR. Combined allergic rhinitis and asthma syndrome (CARAS). Int Immunopharmacol. 2019;74:105718. doi:10.1016/j.intimp.2019.105718
   PubMed Web of Science ®Google Scholar
• Kim JK, Lee SH, Lee BH, et al. Factors associated with exacerbation in mild- to-moderate COPD patients. Int J Chron Obstruct Pulmon Dis. 2016;11:1327–1333. doi:10.2147/COPD.S105583
   PubMed Web of Science ®Google Scholar
• Jamieson DB, Matsui EC, Belli A, et al. Effects of allergic phenotype on respiratory symptoms and exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(2):187–192. doi:10.1164/rccm.201211-2103OC
   PubMed Web of Science ®Google Scholar
• Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet. 2011;378(9809):2112–2122. doi:10.1016/S0140-6736(11)60130-X
   PubMed Web of Science ®Google Scholar
• Yorgancioglu A, Ozdemir C, Kalayci O, et al. [ARIA (Allergic Rhinitis and its Impact on Asthma) achievements in 10 years and future needs]. Tuberk Toraks. 2012;60(1):92–97. Indonesian. doi:10.5578/tt.3734
   PubMedGoogle Scholar
• Wei B, Sheng LC. Changes in Th1/Th2-producing cytokines during acute exacerbation chronic obstructive pulmonary disease. J Int Med Res. 2018;46(9):3890–3902. doi:10.1177/0300060518781642
   PubMed Web of Science ®Google Scholar
• Jiang M, Liu H, Li Z, et al. ILC2s induce adaptive Th2-type immunity in acute exacerbation of chronic obstructive pulmonary disease. Mediators Inflamm. 2019;2019:3140183. doi:10.1155/2019/3140183
   PubMed Web of Science ®Google Scholar
• Navarro A, Costa R, Rodriguez-Carballeira M, et al. Prognostic assessment of mortality and hospitalizations of outpatients with advanced chronic obstructive pulmonary disease. Usefulness of the CODEX index. Rev Clin Esp. 2015;215(8):431–438. doi:10.1016/j.rce.2015.06.004
   PubMed Web of Science ®Google Scholar
• Hadda V, Madan K, Mohan A. CODEX index and prognosis of patients with exacerbation of COPD. Chest. 2014;145(5):1172. doi:10.1378/chest.13-2516
   PubMed Web of Science ®Google Scholar
• Chen CZ, Ou CY, Yu CH, Yang SC, Chang HY, Hsiue TR. Comparison of global initiative for chronic obstructive pulmonary disease 2013 classification and body mass index, airflow obstruction, dyspnea, and exacerbations index in predicting mortality and exacerbations in elderly adults with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2015;63(2):244–250. doi:10.1111/jgs.13258
   PubMed Web of Science ®Google Scholar